Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-15 1:19 pm Purchase |
2022-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Western Standard, LLC | 424,080 6.600% |
41,507 (+10.85%) |
Filing History |
| 2022-11-28 4:07 pm Purchase |
2022-11-16 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Western Standard, LLC | 382,573 6.000% |
382,573 (New Position) |
Filing History |
| 2022-06-17 4:53 pm Sale |
2022-01-26 | 13D | Opiant Pharmaceuticals, Inc. OPNT |
CRYSTAL ROGER | 636,594 11.200% |
-96,881 (-13.21%) |
Filing History |
| 2022-06-17 4:52 pm Sale |
2021-08-23 | 13D | Opiant Pharmaceuticals, Inc. OPNT |
Sinclair Michael | 515,170 9.300% |
-230,000 (-30.87%) |
Filing History |
| 2022-02-11 09:32 am Sale |
2021-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Renaissance Technologies LLC | 183,815 3.890% |
-53,000 (-22.38%) |
Filing History |
| 2022-01-27 10:12 am Sale |
2021-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
WELLS FARGO & CO WFC |
224,297 4.750% |
-27,908 (-11.07%) |
Filing History |
| 2021-02-16 2:28 pm Sale |
2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Radoff Bradley Louis | 18,000 1.000% |
-259,500 (-93.51%) |
Filing History |
| 2021-02-12 5:08 pm Sale |
2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Stonepine Capital Management, LLC | 0 0.000% |
-334,272 (Position Closed) |
Filing History |
| 2021-02-11 4:37 pm Purchase |
2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
WELLS FARGO & CO WFC |
252,205 5.920% |
252,205 (New Position) |
Filing History |
| 2021-02-11 2:04 pm Sale |
2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Altium Capital Management LLC | 0 0.000% |
-349,846 (Position Closed) |
Filing History |
| 2021-02-10 4:09 pm Purchase |
2020-07-17 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Renaissance Technologies LLC | 236,815 5.560% |
236,815 (New Position) |
Filing History |